Posttraumatic stress symptoms
Conditions
Interventions
Participants are divided into the PTSS group, PTSD group and healthy control. PTSS group: patients with post-traumatic stress symptoms(PTSS) who have traumatic experiences that do not meet the A crit
Sponsors
Hamamatsu University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: PTSS group 1.Aged 20 to 55 years old. 2.Subjects who have traumatic experiences that do not meet the A criterion for PTSD in DSM-5. 3.Subjects who meet two or more of the B-E criteria for PTSD in DSM-5 and who meet the F and G criteria. 4.Intelligent quotient above 80 by JART. 5.Subjects who give full consent in the participation of the study. PTSD group 1.Aged 20 to 55 years old. 2.Subjects who meet the diagnostic criteria for PTSD in DSM-5 as a primary diagnostic. 3.Intelligent quotient above 80. 4.Subjects who give full consent in the participation of the study. healthy control 1.Aged 20 to 55 years old. 2.Intelligent quotient above 80. 3.Subjects who give full consent in the participation of the study.
Exclusion criteria
Exclusion criteria: PTSS group 1.Prior treatment of EMDR. 2.Subjects who have a high urgency for treatment, such as an imminent suicide attempt. 3.Subjects with intracranial occupational lesions or vascular lesions such as cerebral infarction. 4.Subjects with neurological diseases such as epilepsy. 5.MRI contraindicated. 6.Pregnancy or possible pregnancy. PTSD group 1.Prior treatment of EMDR. 2.Subjects whose main diagnosis is mental disorders other than PTSD. 3.Subjects who have a high urgency for treatment, such as an imminent suicide attempt. 4.Subjects with intracranial occupational lesions or vascular lesions such as cerebral infarction. 5.Subjects with neurological diseases such as epilepsy. 6.MRI contraindicated. 7.Pregnancy or possible pregnancy. healthy control 1.Subjects who suspected of mental disorder by M.I.N.I
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| resting-state fMRI before and after EMDR treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinician-Administered PTSD Dissociative Experiences Scale-2 Impact of Event Scale-revised Beck Depression Inventory-2 State-Trait Anxiety Inventory Posttraumatic Cognition Inventory Multidimensional Assessment of Interoceptive Awareness Toronto Alexithymia Scale MRI T1-weighted image T2-weighted image 1H-MRS | — |
Countries
Japan
Contacts
Public ContactJun Inoue
Hamamatsu University School of Medicine Department of Child and Adolescent Psychiatry
Outcome results
None listed